Skip to main content

Main navigation

  • Rare Disease Research
    • Find Diseases We Study
    • Rare Diseases Research Groups & Studies
    • Publications
  • Patients and Families
    • Patient Organizations
    • Survey on Impacts of COVID-19
    • Additional Resources
  • Researchers
    • COVID-19 Impacts on Research
    • RDCRN Conference on Clinical Research for Rare Diseases (CCRRD)
      • Resources From Past CCRRD Conferences
    • RDCRN Training Opportunities
    • Other Rare Disease Initiatives
    • NIH Data Sharing
  • News
  • About Us
facebook twitter linkedin RDCRN Members Login

Resources for Research Impacted by COVID-19

  • The Rare Diseases Clinical Research Network is funded by the National Institutes of Health (NIH). View resources for researchers here.
  • Get the latest information on research impacts from NIH: www.nih.gov/coronavirus
  • Get the latest public health information from CDC: www.coronavirus.gov
Home
facebook twitter linkedin RDCRN Members Login
  • Rare Disease Research
    • Find Diseases We Study
    • Rare Diseases Research Groups & Studies
    • Publications
  • Patients and Families
    • Patient Organizations
    • Survey on Impacts of COVID-19
    • Additional Resources
  • Researchers
    • COVID-19 Impacts on Research
    • RDCRN Conference on Clinical Research for Rare Diseases (CCRRD)
      • Resources From Past CCRRD Conferences
    • RDCRN Training Opportunities
    • Other Rare Disease Initiatives
    • NIH Data Sharing
  • News
  • About Us

Spotlight On Rare Diseases

Tweets by rarediseasesnet

Tags

CDG
CF
FCDGC
primary ciliary dyskinesia
Genetic Disorders of Mucociliary Clearance Consortium
PCD
GDMCC
COVID-19
mucociliary clearance
coronavirus


Your participation makes a world of difference.
Learn How

Stay Up To Date With The Spotlight On Rare Diseases Newsletter

Subscribe

About Spotlight

Footer Bottom Links

  • Contact Us
  • Accessibility & Disclaimer
    • facebook
    • twitter
    • linkedin
The Rare Diseases Clinical Research Network is an initiative of the Office of Rare Diseases Research. National Center for Advancing Translational Sciences (NCATS) funded through a collaboration between NCATS and the National Institutes of Health.